Stay updated on Pembrolizumab with Targeted Therapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Targeted Therapy Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The webpage has been updated to include new information about various types of recurrent and refractory lymphomas, as well as details about a clinical trial involving pembrolizumab and its identifiers. The previous content regarding the trial's objectives and treatment protocols has been significantly reduced.
    Difference
    52%
    Check dated 2025-04-16T20:37:25.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.4%
    Check dated 2025-04-09T15:00:13.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.6%
    Check dated 2025-04-02T00:24:24.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-25T17:48:23.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-03-11T08:42:13.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-03-04T04:53:37.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Targeted Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.